Baird lowered the firm’s price target on Xponential Fitness (XPOF) to $13 from $15 and keeps a Neutral rating on the shares. The firm said Q3 revenue beat, while adjusted EBITDA fell short on lower margin performance.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.